Congenital cancer
Pro Research Analysisby 
Searched over 200M research papers for "congenital cancer"
Congenital Cancer: Definitions and Key Concepts
Congenital cancers are rare tumors that are present at birth or develop shortly after. These tumors are unique because they often arise before there is time for multiple genetic mutations to accumulate, as seen in adult cancers. Instead, congenital tumors tend to be genomically and chromosomally similar to the host and often reflect developmental processes, sometimes blurring the line between tumor and maldevelopment. Recent advances in genetics have highlighted the importance of pathways involved in cellular differentiation, imprinting, chromatin remodeling, and noncoding RNA in the development of these tumors .
Genetic Predisposition and Cancer Risk in Children with Congenital Anomalies
Multiple large-scale studies have shown that children with congenital anomalies, both chromosomal and non-chromosomal, have a significantly higher risk of developing cancer compared to children without such anomalies. The risk is especially high in the first year of life and for certain cancer types, such as leukemia, central nervous system tumors, sympathetic nervous system tumors, and soft tissue sarcomas 2468. Children with Down syndrome, nervous system anomalies, and urinary system anomalies are at particularly high risk 4810.
Specific Congenital Anomalies and Associated Cancer Types
Certain congenital defects are strongly linked to specific cancers. For example:
- Down syndrome is closely associated with an increased risk of leukemia 4810.
- Congenital hemihypertrophy is linked to Wilms' tumor, primary liver cancer, and adrenocortical neoplasia .
- Aniridia is also associated with Wilms' tumor, independent of hemihypertrophy .
- Children with congenital heart disease (CHD) have a higher risk of thyroid and skin cancers, as well as lymphoma and hepatoblastoma, especially in those with complex CHD 79.
Underlying Genetic Mechanisms and Novel Associations
Recent genetic studies have found a high frequency of deleterious germline mutations in cancer predisposition genes among children with both cancer and congenital anomalies. Many of these mutations are in genes not traditionally linked to the specific tumor type, suggesting the possibility of oligogenic inheritance, where multiple genes together increase cancer risk. Novel gene-phenotype associations have also been identified, such as SETD5 in neuroblastoma and KAT6A in gliomas . Comprehensive genetic analysis is therefore crucial for understanding cancer risk in children with congenital anomalies and for guiding clinical management .
Implications for Surveillance and Clinical Practice
The strong association between congenital anomalies and childhood cancer highlights the need for careful clinical surveillance of children with birth defects. These findings suggest that congenital anomalies may serve as markers for underlying genetic or environmental exposures that increase cancer risk. Enhanced screening protocols and genetic counseling may be warranted for children with certain congenital conditions 2458+1 MORE.
Conclusion
Congenital cancers and the increased cancer risk in children with congenital anomalies are closely linked to genetic and developmental factors. Understanding these associations is essential for early detection, targeted surveillance, and improved outcomes in affected children. Ongoing research into the genetic underpinnings of these conditions continues to reveal new insights and potential avenues for therapy and prevention 1245+5 MORE.
Sources and full results
Most relevant research papers on this topic